Internal Medicine Alert (Vol. 38, No. 5) - March 15, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: March 2016

Valid through: March 2019

Target Audience

This CME activity is intended for the internist/family physician.

Subjects

  • Is Sodium Restriction Detrimental in Chronic Heart Failure?
  • Spironolactone for Resistant Hypertension
  • Optimal Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke
  • Pharmacology Update: Patiromer for Oral Suspension (Veltassa)
  • Clinical Briefs: Sexual Health Supplement Leads to Priapism; Eluxadoline for IBS-D; New Orthostatic Hypotension Category
  • ECG Review: Chest Pain, Dyspnea, and Anterior T Wave Inversion

Objectives

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • Identify cost-effective treatment regimens
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available

Physicians

  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

Internal Medicine Alert has been reviewed and is acceptable for up to 1.0 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins Jan. 1, 2016. Term of approval is for one year from this date with the option of yearly renewal.

Faculty Listing

EDITOR

Stephen A. Brunton, MD

Adjunct Professor of Pharmacy Practice

College of Pharmacy

Roseman University of Health Sciences

Salt Lake City 

 

ASSOCIATE EDITORS

James Chan, PharmD, PhD

Pharmacy Quality and Outcomes Manager

Kaiser Permanente

Oakland, CA

 

Michael Crawford, MD

Professor of Medicine, Chief of Clinical Cardiology

University of California, San Francisco

 

William T. Elliott, MD, FACP

Chair, Formulary Committee

Northern California Kaiser Permanente

Assistant Clinical Professor of Medicine
University of California, San Francisco

 

Matthew E. Fink, MD

Professor and Chairman, Department of Neurology

Weill Cornell Medical College

Neurologist-in-Chief

New York Presbyterian Hospital

 

Ken Grauer, MD

Professor Emeritus in Family Medicine

College of Medicine

University of Florida

 

Louis Kuritzky, MD

Clinical Assistant Professor

University of Florida

 

Van Selby, MD

Assistant Professor of Medicine

UCSF Cardiology Division, Advanced Heart Failure Section

San Francisco

 

PEER REVIEWER

Gerald Roberts, MD

Senior Attending Physician Long Island Jewish Medical Center NS/LIJ Health Care System

New Hyde Park, NY

 

Financial Disclosure

Internal Medicine Alert’s editor Stephen Brunton, MD, is a retained consultant for Abbott, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Exact Sciences, Janssen, Lilly, Mylan, Novo Nordisk, and Teva; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing editor Louis Kuritzky is a retained consultant for AbbVie, Allergan, AstraZeneca, Janssen, Lilly, Lundbeck, Medscape, Novo Nordisk, and Sanofi Aventis; he serves on the speakers bureau of Lilly and Lundbeck. Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Drs. Elliott, Chan, Crawford, and Selby report no financial relationships relevant to this field of study.

Dr. Fink reports he is a retained consultant for Procter & Gamble and Pfizer.

Dr. Grauer is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book.

Copyright 2016, AHC Media. All rights reserved.